Expressing support for the designation of September 2023 as "Peripheral Artery Disease Awareness Month".
Impact
This resolution serves as a platform to promote education and awareness programs designed to inform the public about PAD and its risk factors, which include smoking, diabetes, and high blood pressure. By encouraging screenings and early diagnosis, the resolution aims to prevent unnecessary amputations and improve quality of life for those affected by PAD. Moreover, its focus on minority communities emphasizes the need to address healthcare disparities that exist in the diagnosis and management of chronic conditions like PAD.
Summary
House Resolution 728 expresses support for the designation of September 2023 as 'Peripheral Artery Disease Awareness Month'. It highlights the importance of raising public awareness regarding Peripheral Artery Disease (PAD), a chronic condition that affects approximately 20 million Americans. The resolution aims to bring attention to the serious health implications of PAD, including increased risks of heart attacks, strokes, and non-traumatic amputations, particularly among high-risk populations, including African Americans and older adults.
Contention
While the resolution is generally non-controversial as it does not impose any mandates or change existing laws, potential contention may arise in discussions around funding and resources for awareness initiatives. Advocates for PAD awareness and public health insist that without adequate support from both governmental and non-governmental organizations, educational efforts may lack effectiveness. Additionally, debates could focus on how best to allocate funds for public health versus other competing health priorities.
Expressing support for the designation of September 2024 as "National Polycystic Kidney Disease Awareness Month", and raising awareness and understanding of polycystic kidney disease.